She recently completed a study evaluating the impairments experienced by patients with bladder cancer who had radical surgery.ĭr. Her work focuses on strategies to improve patient outcomes and quality of life after surgical treatments. Lee has served as principal investigator, co-principal investigator, site principal investigator, or co-investigator for 50 clinical research trials supported by a broad range of funders, including the National Institutes of Health. As a member of the University of Michigan Comprehensive Cancer Center, she cared primarily for patients with bladder cancer.ĭr. Lee, a tenured Professor of Urology and an expert in outcomes research and comparative studies, joins The Ohio State from the University of Michigan, where she was the Dr. She will also be appointed the Dorothy M. Lee will be Chair of the Medical Center’s Department of Urology.
The Ohio State University Wexner Medical Center has named a prominent expert in bladder cancer, Cheryl Taylore Lee, MD, to lead its urology, uro/gynecology, and uro/oncologic programs, beginning July 1, pending approval by The Ohio State University Board of Trustees.ĭr.
